The role of the 5-hydroxytryptamine (5-HT) system in migraine has long been well-established (62), particularly with the extensive clinical use and widespread recognition of several triptans targeting the 5-HT1B/1D receptors (58). Here, HTR5A is linked to migraine disorder.